Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Journal of Psychiatric Research|June 27, 2022
Analysis of color vision and cognitive function in first-episode schizophrenia before and after antipsychotic treatmentLi Duan, Chunsheng Tian, Chunfeng Fu, et al.
Bioresource Technology|June 12, 2016
Pretreatment of non-sterile, rotted silage maize straw by the microbial community MC1 increases biogas productionBinbin Hua, Jiali Dai, Bin Liu, et al.
Frontiers in Oncology|April 1, 2022
Deleterious <i>AHNAK2</i> Mutation as a Novel Biomarker for Immune Checkpoint Inhibitors in Non-Small Cell Lung CancerYanan Cui, Xinyin Liu, Yuemin Wu, et al.
Cell Death & Disease|May 8, 2023
LncRNA LINC00969 promotes acquired gefitinib resistance by epigenetically suppressing of NLRP3 at transcriptional and posttranscriptional levels to inhibit pyroptosis in lung cancerJiali Dai, Tianyu Qu, Dandan Yin, et al.
BMC Psychiatry|March 4, 2024
Mixed-Mode Mindfulness-based cognitive therapy for psychological resilience, Self Esteem and Stigma of patients with schizophrenia: a randomized controlled trialJiali Dai, Dawei Sun, Bohui Li, et al.
Frontiers in Psychiatry|June 25, 2021
Based on a Decision Tree Model for Exploring the Risk Factors of Smartphone Addiction Among Children and Adolescents in China During the COVID-19 PandemicLi Duan, Juan He, Min Li, et al.
Journal of Cellular and Molecular Medicine|June 6, 2023
Pemetrexed induces ROS generation and cellular senescence by attenuating TS-mediated thymidylate metabolism to reverse gefitinib resistance in NSCLCYun Chen, Chen Zhang, Shidai Jin, et al.
Thoracic Cancer|January 3, 2023
Efficacy and safety of antiangiogenic agents or chemotherapy plus EGFR-TKIs in advanced non-small cell lung cancer: A systematic review and network meta-analysisJiali Dai, Xinyin Liu, Jun Li, et al.
Frontiers in Genetics|January 26, 2023
PBRM1 mutation as a predictive biomarker for immunotherapy in multiple cancersJiali Dai, Yanan Cui, Xiao Liang, et al.
Medicine|June 23, 2020
Pyrotinib in the treatment of human epidermal growth factor receptor 2-positive metastatic breast cancer: A case reportJiali Dai, Yuetong Chen, Cuiju Tang, et al.
Pageof 5